Insufficient scRNA-seq data for expression of RFPL1 at single-cell level.
Insufficient scRNA-seq data for expression of RFPL1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 75% | 12.48 | 183 / 245 | 2% | 0.03 | 10 / 502 |
spleen | 61% | 3.50 | 146 / 241 | 0% | 0 | 0 / 0 |
liver | 52% | 4.36 | 118 / 226 | 0% | 0 | 0 / 406 |
ovary | 50% | 2.16 | 90 / 180 | 0% | 0.04 | 1 / 430 |
adrenal gland | 49% | 1.77 | 126 / 258 | 0% | 0 | 0 / 230 |
brain | 45% | 1.73 | 1188 / 2642 | 0% | 0 | 0 / 705 |
uterus | 11% | 0.28 | 19 / 170 | 0% | 0 | 0 / 459 |
kidney | 8% | 0.24 | 7 / 89 | 0% | 0 | 0 / 901 |
intestine | 6% | 0.13 | 56 / 966 | 0% | 0 | 0 / 527 |
pancreas | 5% | 0.13 | 15 / 328 | 1% | 0.02 | 2 / 178 |
breast | 4% | 0.18 | 20 / 459 | 0% | 0 | 0 / 1118 |
peripheral blood | 4% | 0.10 | 40 / 929 | 0% | 0 | 0 / 0 |
thymus | 4% | 0.10 | 27 / 653 | 0% | 0 | 0 / 605 |
lung | 4% | 0.09 | 23 / 578 | 0% | 0.00 | 1 / 1155 |
esophagus | 4% | 0.10 | 56 / 1445 | 0% | 0 | 0 / 183 |
adipose | 3% | 0.08 | 35 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 3% | 0.06 | 34 / 1335 | 0% | 0 | 0 / 0 |
heart | 2% | 0.05 | 21 / 861 | 0% | 0 | 0 / 0 |
skin | 2% | 0.06 | 44 / 1809 | 0% | 0 | 0 / 472 |
stomach | 2% | 0.04 | 7 / 359 | 0% | 0 | 0 / 286 |
muscle | 1% | 0.02 | 7 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 0% | 0 | 0 / 504 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0000209 | Biological process | protein polyubiquitination |
GO_0045087 | Biological process | innate immune response |
GO_0032436 | Biological process | positive regulation of proteasomal ubiquitin-dependent protein catabolic process |
GO_0051782 | Biological process | negative regulation of cell division |
GO_0032880 | Biological process | regulation of protein localization |
GO_2001272 | Biological process | positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_0010972 | Biological process | negative regulation of G2/M transition of mitotic cell cycle |
GO_0045930 | Biological process | negative regulation of mitotic cell cycle |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0046596 | Biological process | regulation of viral entry into host cell |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | RFPL1 |
Protein name | Ret finger protein-like 1 (RING finger protein 78) |
Synonyms | RNF78 RFPL1L |
Description | FUNCTION: Negatively regulates the G2-M phase transition, possibly by promoting cyclin B1/CCNB1 and CDK1 proteasomal degradation and thereby preventing their accumulation during interphase. . |
Accessions | ENST00000354373.2 O75677 |